Gujarat Terce Laboratories Board to Consider Q2 and H1 FY27 Results on 5th Nov'26
Gujarat Terce Laboratories Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Gujarat Terce Laboratories Board to Consider Q2 and H1 FY27 Results on 5th Nov'26 Gujarat Terce Laboratories Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone financial results for the second quarter and half year ended 30th Sep'26, subject to a limited review by statutory auditors. In compliance with insider trading regulations, the company's trading window for dealing in its securities remains closed from 1st Oct'26 until 7th Nov'26, concluding 48 hours post the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Gujarat Terce Laboratories Ltd
- Detailed disclosure is attached. 路 05 Nov 2026
- Detailed disclosure is attached. 路 05 Nov 2026
- In compliance with Regulation 30 read with Schedule III, Regulation 33 and other applicable provisions of the SEBI Listing Regulations, the Board of Directors of Gujarat Terce Laboratories .... 路 05 Nov 2026
- Detailed disclosure is attached 路 21 Aug 2026
- Detailed disclosure is attached. 路 21 Aug 2026
- Detailed disclosure is attached. 路 21 Aug 2026
- Corrigendum/Revised intimation regarding Re-appointment of Managing Director & Chief Executive Officer of the Company- Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) .... 路 21 Aug 2026
- Detailed disclosure is attached. 路 07 Aug 2026
